Published in Pharm World Sci on February 23, 2008
Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance. Int J Pharm (2010) 1.01
Gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis: safety, efficacy and patient perspective. Ophthalmol Eye Dis (2012) 0.75
Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother (2007) 2.99
Validity and reliability of measurement instruments used in research. Am J Health Syst Pharm (2008) 2.64
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2011) 1.80
Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm (2003) 1.69
Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications. Arch Pediatr Adolesc Med (2011) 1.68
Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm (2005) 1.48
Pharmacy resident project publication rates and study designs from 1981, 1991, and 2001. Am J Health Syst Pharm (2010) 1.41
Effects of concomitant amiodarone and haloperidol on Q-Tc interval prolongation. Am J Health Syst Pharm (2008) 1.41
Small budget impact is a result of flawed assumptions and ignores questionable cost-effectiveness for RSV prophylaxis. Value Health (2010) 1.39
Factors associated with the publication of scholarly articles by pharmacists. Am J Health Syst Pharm (2011) 1.12
Nature and causes of clinically significant medication errors in a tertiary care hospital. Am J Health Syst Pharm (2004) 1.05
Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2009) 1.05
Oral phenylephrine: an ineffective replacement for pseudoephedrine? J Allergy Clin Immunol (2006) 0.98
Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery. J Thorac Cardiovasc Surg (2009) 0.97
Emerging roles for pharmacists in clinical implementation of pharmacogenomics. Pharmacotherapy (2014) 0.96
Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida. J Pediatr (2010) 0.94
Polypharmacy in attention deficit hyperactivity disorder treatment: current status, challenges and next steps. Curr Psychiatry Rep (2012) 0.92
An in-depth analysis of medication errors in hospitalized patients with HIV. Ann Pharmacother (2011) 0.92
Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion. Ann Pharmacother (2011) 0.91
Evaluation of drug interaction software to identify alerts for transplant medications. Ann Pharmacother (2004) 0.89
An algorithm to identify preterm infants in administrative claims data. Pharmacoepidemiol Drug Saf (2012) 0.89
Automatic replacement of albuterol nebulizer therapy by metered-dose inhaler and valved holding chamber. Am J Health Syst Pharm (2005) 0.87
Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports. Am J Health Syst Pharm (2002) 0.87
Evaluation of online drug references for identifying over-the-counter solid oral dosage forms. J Am Pharm Assoc (2003) (2005) 0.86
Patient counseling practices in U.S. pharmacies: effects of having pharmacists hand the medication to the patient and state regulations on pharmacist counseling. J Am Pharm Assoc (2003) (2011) 0.86
Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Ann Pharmacother (2007) 0.85
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure. Pharmacotherapy (2006) 0.85
Evaluation of electronic databases used to identify solid oral dosage forms. Am J Health Syst Pharm (2003) 0.84
Antihypertensive drug class interactions and risk for incident diabetes: a nested case-control study. J Am Heart Assoc (2013) 0.83
Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD. Pharmacoepidemiol Drug Saf (2010) 0.82
Automated medication error studies with audit supplementation were effectively designed and analyzed by time series. J Clin Epidemiol (2006) 0.81
Planning for pharmacy health information technology in critical access hospitals. Am J Health Syst Pharm (2007) 0.81
Projecting the effect of nesiritide on dialysis and hospital mortality in cardiac surgery patients. Value Health (2010) 0.80
Patient understanding of drug risks: an evaluation of medication guide assessments. Pharmacoepidemiol Drug Saf (2015) 0.78
Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy. BMC Med Res Methodol (2012) 0.78
Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Atherosclerosis (2013) 0.77
Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Curr Med Res Opin (2014) 0.76
Anti-diabetic drug utilization of pregnant diabetic women in us managed care. BMC Pregnancy Childbirth (2014) 0.76
Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol (2006) 0.76
Effect of an academic detailing intervention on the utilization rate of cyclooxygenase-2 inhibitors in the elderly. Ann Pharmacother (2008) 0.76
Issues in medication safety. Am J Health Syst Pharm (2007) 0.75
Comment: Azithromycin for gastroparesis. Ann Pharmacother (2013) 0.75
Response to respiratory synctial virus. South Med J (2008) 0.75
RE: Drug risk assessment and data reuse. Pharmacoepidemiol Drug Saf (2014) 0.75
Response to Letter to the editor regarding Sensorineural hearing loss associated with neomycin eardrops and nonintact tympanic membranes. Otolaryngol Head Neck Surg (2013) 0.75
Comment: Pharmacy and generic substitution of antiepileptic drugs: missing in action? Ann Pharmacother (2007) 0.75
Intensive glucose lowering and cardiovascular outcomes. N Engl J Med (2011) 0.75
Methodological Concerns Regarding Cost-effectiveness Analysis of Palivizumab in Florida Medicaid-Reply. Arch Pediatr Adolesc Med (2012) 0.75
Epidemiology of Persistent Tympanic Membrane Perforations Subsequent to Tympanostomy Tubes Assessed With Real World Data. Otol Neurotol (2016) 0.75
Development of a Medication Safety and Quality Survey for Small Rural Hospitals. J Patient Saf (2017) 0.75
Use of oral ketamine by academic hospitals in the US. Ann Pharmacother (2013) 0.75
A tool kit for practice-based research. Am J Health Syst Pharm (2008) 0.75
Topical dexamethasone and tympanic membrane perforation healing in otitis media: a short-term study. Otol Neurotol (2010) 0.75
Negative Results Do Not Imply Absence of Ototoxicity with Middle Ear Application of Neomycin. Otolaryngol Head Neck Surg (2014) 0.75
Consistency of psychotropic drug-drug interactions listed in drug monographs. J Am Pharm Assoc (2003) (2017) 0.75
Perioperative medication errors in otolaryngology. Laryngoscope (2010) 0.75
Evaluation of seven i.v. drug compatibility references by using requests from a drug information center. Am J Health Syst Pharm (2009) 0.75
Pharmacists and industry: guidelines for ethical interactions. Pharmacotherapy (2008) 0.75
A survey of intravenous immune globulin (IVIG) dosing strategies. Ann Pharmacother (2015) 0.75